Cargando…

How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi

BACKGROUND: Pregnant and breastfeeding women are at an increased risk of severe illness from COVID-19 compared to people who are not pregnant. Therefore, the CDC recommends COVID-19 vaccination for women who are pregnant, breastfeeding, and trying to become pregnant or who may become pregnant in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianchi, FP, Stefanizzi, P, Di Gioia, MC, Brescia, N, Lattanzio, S, Tafuri, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594199/
http://dx.doi.org/10.1093/eurpub/ckac129.665
_version_ 1784815355183497216
author Bianchi, FP
Stefanizzi, P
Di Gioia, MC
Brescia, N
Lattanzio, S
Tafuri, S
author_facet Bianchi, FP
Stefanizzi, P
Di Gioia, MC
Brescia, N
Lattanzio, S
Tafuri, S
author_sort Bianchi, FP
collection PubMed
description BACKGROUND: Pregnant and breastfeeding women are at an increased risk of severe illness from COVID-19 compared to people who are not pregnant. Therefore, the CDC recommends COVID-19 vaccination for women who are pregnant, breastfeeding, and trying to become pregnant or who may become pregnant in the future. Despite this, low vaccination coverages are reported in this population sub-group. The purpose of this study is to estimate the proportion of pregnant and breastfeeding women expressing hesitation to the COVID-19 vaccine worldwide. Determinants of vaccine compliance and options suggestedto address vaccine hesitancy were also analyzed. METHODS: Forty-six studies were included in the meta-analysis and systematic review, selected from scientific articles available in the MEDLINE/PubMed, Google Scholar, and Scopus databases between January 1, 2020 and February 6, 2022. The following terms were used for the search strategy: (adherence OR hesitancy OR compliance OR attitude) AND (covid* OR SARS*) AND (vaccin* OR immun*) AND (pregnan* OR post-partum OR breastfeeding OR lactating). RESULTS: The vaccine hesitation rate was 48.4% (95%CI=43.4-53.4%). In a sub analysis by study period, the pooled prevalence of vaccine hesitation was 40.0% (95%CI=31.6-46.6%) considering surveys administered in 2020, 58.0% (95%CI=48.9-66.9%) considering surveys administered in the first semester of 2021, and 38.1% (95%CI=25.9-51.2%) considering surveys administered in the second semester of 2021. The main reasons for vaccine hesitation were lack of information about vaccination, opinion that the vaccine is unsafe, and fear of adverse events for both mother and fetus/child. CONCLUSIONS: In order to achieve high vaccination coverage, a multifactorial approach is needed, requiring major social, scientific, and health efforts. The success of the vaccination campaign in this population depends on the capillarity and consistency of the interventions implemented. KEY MESSAGES: • Vaccine hesitancy can be a determining factor in the success (or otherwise) of the anti-COVID-19 immunization campaign. • Vaccine hesitancy in pregnant and breastfeeding women is a genuine public health concern worldwide.
format Online
Article
Text
id pubmed-9594199
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95941992022-11-04 How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi Bianchi, FP Stefanizzi, P Di Gioia, MC Brescia, N Lattanzio, S Tafuri, S Eur J Public Health Parallel Programme BACKGROUND: Pregnant and breastfeeding women are at an increased risk of severe illness from COVID-19 compared to people who are not pregnant. Therefore, the CDC recommends COVID-19 vaccination for women who are pregnant, breastfeeding, and trying to become pregnant or who may become pregnant in the future. Despite this, low vaccination coverages are reported in this population sub-group. The purpose of this study is to estimate the proportion of pregnant and breastfeeding women expressing hesitation to the COVID-19 vaccine worldwide. Determinants of vaccine compliance and options suggestedto address vaccine hesitancy were also analyzed. METHODS: Forty-six studies were included in the meta-analysis and systematic review, selected from scientific articles available in the MEDLINE/PubMed, Google Scholar, and Scopus databases between January 1, 2020 and February 6, 2022. The following terms were used for the search strategy: (adherence OR hesitancy OR compliance OR attitude) AND (covid* OR SARS*) AND (vaccin* OR immun*) AND (pregnan* OR post-partum OR breastfeeding OR lactating). RESULTS: The vaccine hesitation rate was 48.4% (95%CI=43.4-53.4%). In a sub analysis by study period, the pooled prevalence of vaccine hesitation was 40.0% (95%CI=31.6-46.6%) considering surveys administered in 2020, 58.0% (95%CI=48.9-66.9%) considering surveys administered in the first semester of 2021, and 38.1% (95%CI=25.9-51.2%) considering surveys administered in the second semester of 2021. The main reasons for vaccine hesitation were lack of information about vaccination, opinion that the vaccine is unsafe, and fear of adverse events for both mother and fetus/child. CONCLUSIONS: In order to achieve high vaccination coverage, a multifactorial approach is needed, requiring major social, scientific, and health efforts. The success of the vaccination campaign in this population depends on the capillarity and consistency of the interventions implemented. KEY MESSAGES: • Vaccine hesitancy can be a determining factor in the success (or otherwise) of the anti-COVID-19 immunization campaign. • Vaccine hesitancy in pregnant and breastfeeding women is a genuine public health concern worldwide. Oxford University Press 2022-10-25 /pmc/articles/PMC9594199/ http://dx.doi.org/10.1093/eurpub/ckac129.665 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Parallel Programme
Bianchi, FP
Stefanizzi, P
Di Gioia, MC
Brescia, N
Lattanzio, S
Tafuri, S
How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi
title How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi
title_full How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi
title_fullStr How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi
title_full_unstemmed How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi
title_short How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi
title_sort how to deal with covid-19 vaccine hesitancy in pregnant and breastfeeding women? a meta-analysis: francesco paolo bianchi
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594199/
http://dx.doi.org/10.1093/eurpub/ckac129.665
work_keys_str_mv AT bianchifp howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi
AT stefanizzip howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi
AT digioiamc howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi
AT brescian howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi
AT lattanzios howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi
AT tafuris howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi